• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    International journal of fertility

    International journal of fertility

    JournalISSN 0020-725X

    年发文量

    研究主题

    论文(2082)

    排序
    1Mood Disorders in the Female Patient.
    G Redmond

    Disruptive changes in mood and low energy level are among the most common reasons women consult a physician. Usually no clear physiological explantation for these changes can be found. Many physicians feel uncomfortable dealing with patients with these complaints. The purpose of this paper is to discuss a practical approach to helping women with such conditions. A variety of terms have been utilized to refer to the situation in which a female patient has decreased energy or labile mood. Premenstrual Syndrome (PMS) and chronic fatigue syndrome (CFS) are currently popular terms. An association of low mood with menstrual cycle phase is undoubted, with the late luteal-early premenstrual phase most commonly associated with depression and irritability. It seems likely that women with PMS and those without it do not differ in circulating hormone levels during their cycles but rather in the brain response to these. Estrogen and progesterone receptors exist in the brain and change during the cycle. Elaborate diagnostic efforts are rarely rewarding in managing mood and energy disorders. Of more value is a careful history particularly concerned with the pattern of mood changes and with life stresses, accompanied by a thorough physical examination and laboratory tests. In most cases, changes in mood and energy are a variant of clinical depression. Changes in energy and sleep may be more evident than low affect. Treatment with an appropriate antidepressant, usually a selective serotonin re-uptake inhibitor (SSRI), benefits most of these patients. Allowing the patient to express concerns about stressful life situations is often of great value.

    1997引用:34
    引用
    AI阅读
    加入学术空间
    293218151 A Comparative Multicenter Study of Two Transdermal Estradiol Replacement Therapies in the Treatment of Postmenopausal Symptoms
    HAIM VANLEUSDEN,G ALBERTYN, C VERLAINE, J VANRUYMBEKE

    Objective-Comparison of the effects of treatment of two transdermal therapeutic systems for estrogen replacement therapy with regard to efficacy, tolerability, and acceptance. Design-Open randomized. Setting-Multicenter. Patients and Interventions-A study population of 104 postmenopausal women was randomized on a 1:1 basis to treatment with one of two estradiol patches, Systen(R) (Cilag) and Estraderm(R) (Ciba-Geigy). Outcome Measures-Systolic and diastolic BP, hot flushes, night sweating, fatigue, insomnia, depression, nervousness, headache, vaginal discomfort (efficacy variables); bleeding, dermatological symptoms, comfort and adhesiveness of patch, and other possible causes of discontinuation (tolerability); general evaluation by patient (acceptance). Results-Considering all efficacy variables, 53% of Systen and 46% of Estraderm patients found the therapy satisfactory. Tolerability was somewhat higher in the Systen group. Adhesiveness of the patch was significantly better for Systen. Overall, 79% of Systen patients and 62% of Estraderm patients evaluated treatment as ''good'' or ''very good.'' The majority of patients in both groups found the patch very comfortable or only slightly obtrusive.

    1993引用:4
    引用
    AI阅读
    加入学术空间
    3Ovulation Induction with GnRH Agonist and Human Menopausal Gonadotropins: Response in Patients with One Versus Two Ovaries.
    A S Penzias,J N Gutmann,F N Shamma,A I LaMorte,A H DeCherney

    OBJECTIVE To examine the effect of oophorectomy on response to gonadotropin releasing hormone-agonist/human menopausal gonadotropin (GnRH-a/hMG) for in vitro fertilization (IVF). DESIGN Retrospective review. SETTING Tertiary care academic institution. PATIENTS Ninety-one infertile patients undergoing IVF. Eighty-four women had two ovaries and seven had only one ovary. RESULTS There was no difference observed between women with one versus two ovaries with regard to response to medications, hormone production, number of oocytes retrieved and fertilized, or the number of embryos cleaved and transferred. CONCLUSION Women with only one ovary are at no reproductive disadvantage when undergoing ovulation induction for IVF.

    1993引用:41
    引用
    AI阅读
    加入学术空间
    4Comparative Efficacy of Gestrinone and Danazol in Infertile Women with Endometriosis
    V RUIZVELASCO,JR ARCEO, A ARMESTO

    The relationship between endometriosis and infertility is observed frequently. Patients with both conditions require a conservative approach to their management. Since hormonal therapy is one of those approaches, we sought to compare the efficacy of Danazol and Gestrinone in 80 infertile patients (48 and 32, respectively). Therapy lasted 6 months in both treatment groups, and all patients studied had laboratory tests performed and were clinically evaluated and classified through laparoscopy before and after therapy. The improvement of symptoms and favorable follow-up were similar with both treatments. The reestablishment of menstrual patterns and fertility were also nearly alike in both groups. However, Gestrinone was associated with fewer secondary effects and is easier to administer than Danazol. We conclude that Gestrinone is a useful medication in the management of the infertile patient with endometriosis.

    1993引用:24
    引用
    AI阅读
    加入学术空间
    5A Comparison Of Hormonal And Ultrasound Assessment Of Pituitary Suppression After Pretreatment With A Gonadotropin-Releasing-Hormone Agonist
    Cj Haines,Epl Loong, Mym Chan,Tkh Chung

    Objective-The purpose of this study was to compare the frequency with which pituitary suppression by gonadotropin releasing hormone agonists (GnRHa) for IVF is achieved according to hormonal vs. ultrasound criteria. Methods-The criteria selected for comparison were a luteinizing hormone (LH) level of <5 mIU/mL, an estradiol of <100 pmol/L and the absence of follicular development >10 mm on ultrasound. Results-Pituitary suppression was achieved in 184/215 cases (85.6%) according to the LH level, in 103/215 cases (47.9%) according to the estradiol level, and in 95/117 cases (81.2%) when ultrasound criteria were satisfied. All three criteria were met in only 16/139 (11.5%) of cases after 3 weeks' pretreatment with the GnRHa. Conclusion-Neither estradiol nor LH levels were predictive of the sonographic evidence of pituitary suppression, nor did they correlate with IVF outcome.

    1993引用:23
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2082 篇论文

    高被引作者

    作者引用发文
    J H Check78623
    Re Boynton6551
    Bw Brown6551
    Bg Behn6551
    AE TRELOAR6551
    Andrew V. Schally63120
    Adelson H G51515
    C H Wu48412
    Abba Kastin46212
    David H Coy44711

    高产作者

    作者引用发文
    Greenste.Js9023
    J H Check78623
    Andrew V. Schally63120
    HW HORNE34517
    Adelson H G51515
    Ah Ansari12413
    C H Wu48412
    Abba Kastin46212
    M Sagiv28511
    Gh Arronet27911

    相关期刊

    暂无数据
    暂无数据